AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gliminyle-M 0.5mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Erinyle Pharma

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Gliminyle-M 0.5mg/500mg Tablet

DiaBeta-Duo 0.5mg/500mg tablets are classified as antidiabetic agents, a combination medication for adult type 2 diabetes management. This dual-action formulation regulates blood glucose. DiaBeta-Duo 0.5mg/500mg tablets should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are vital. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, are recommended by your doctor.

Uses of Gliminyle-M 0.5mg/500mg Tablet

Managing Type 2 diabetes

Major Benefits of Gliminyle-M 0.5mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It's recommended to take the Gliminyle-M 0.5mg/500mg tablet with a meal.

Common Side effects of Gliminyle-M 0.5mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Gliminyle-M 0.5mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gliminyle-M 0.5mg/500mg tablets should be administered with a meal.

How Gliminyle-M 0.5mg/500mg Tablet works:

Each Gliminyle-M 0.5mg/500mg tablet combines glimepiride (a sulfonylurea) and metformin (a biguanide), two medications that manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose. Metformin acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing the body's response to insulin.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Gliminyle-M 0.5mg/500mg tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Gliminyle-M 0.5mg/500mg tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not take Gliminyle-M 0.5mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gliminyle-M 0.5mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. Gliminyle-M 0.5mg/500mg tablets are contraindicated in those with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Gliminyle-M 0.5mg/500mg tablets cautiously. Dosage modifications may be necessary. Physician consultation is advised. For patients experiencing mild to moderate liver disease, Gliminyle-M 0.5mg/500mg tablets are typically initiated at a low dose; however, their use is contraindicated in cases of severe liver dysfunction.

What if you forget to take Gliminyle-M 0.5mg/500mg Tablet :

Should you forget a Gliminyle-M 0.5mg/500mg Tablet dose, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Gliminyle-M 0.5mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Gliminyle-M 0.5mg/500mg Tablet

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Gliminyle-M 0.5mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). While rare, this harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. Seek immediate medical attention, including discontinuing Gliminyle-M 0.5mg/500mg Tablets, if these symptoms occur.
Gliminyle-M 0.5mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 DM.
Gliminyle-M 0.5mg/500mg tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Gliminyle-M 0.5mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and gait problems), urinary issues, cognitive changes, and balance difficulties. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Gliminyle-M 0.5mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Gliminyle-M 0.5mg/500mg tablets with alcohol is unsafe. Alcohol can further lower blood sugar, risking hypoglycemia, and may also increase the risk of lactic acidosis.
Gliminyle-M 0.5mg/500mg T...
37
MRP 45
17% off